Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.

Author: Moogugami Shakalkis
Country: Sweden
Language: English (Spanish)
Genre: Literature
Published (Last): 7 December 2012
Pages: 491
PDF File Size: 4.23 Mb
ePub File Size: 18.89 Mb
ISBN: 206-3-86897-580-2
Downloads: 53715
Price: Free* [*Free Regsitration Required]
Uploader: Yozshujinn

A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.

Tratamiento de las bronquiectasias | Girón Moreno | Monografías de Archivos de Bronconeumología

No adverse events were reported with acebrophylline. Inhaled hyperosmolar agents for bronchiectasis. Nebulized amoxicillin in chronic purulent bronchiectasis.

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease Bronchiectasis Intervention Study: This abstract may be abridged. An elevated bronchodilator response predicts large airway inflammation in mild hi;ersecrecion.

Outcomes of Pseudomonas eradication therapy in patients with non—cystic fibrosis bronchiectasis. EH, Koppers RJ, et al. Eur J Respir Dis Suppl. Inhaled antibiotic therapy in non-cystic hipersecreciom patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.

Clinical interpretation of airway response to a bronchodilator: A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Randomized code was open and the final sample distribution was: Randomized, controlled, double blind, parallel, prospective design with rescue medication.


UK Cystic Fibrosis Trust. Bronchodilator response as a marker of poor asthma control. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. Long-term treatment benefits with tiotropium in COPD patients with and without short-term hiperdecrecion responses. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

However, users may print, download, or email articles for individual use. J Allergy Clin Immunol. TS, Chalmers JD, et al.

Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.

Global Strategy for Asthma Management and Prevention. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial.

Report of the Committe on Emphysema. Phase 3 efficacy and safety data from randomized, multicentre study of liposomal amikacin for inhalation Arikace compared with Tobi R in cystic fibrosis patients with chronic infection due to Hronquial aeruginosa.

Double-blind randomized multicenter study versus placebo.

Monografías de Archivos de Bronconeumología

Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Inhaled penicillin in bronchial infections.

  CBP 7523 PDF

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. A single measure of FEV1 is associated with risk of asthma attacks in long-term bronnquial. British Thoracic Society guideline for non-CF bronchiectasis. Am Rev Respir Dis. Chronic bronchopulmonary diseases involving inflammation, hypersecretion and bronchial hyperreactivity, such as asthma, chronic bronchitis and chronic obstructive pulmonary disease COPD are common causes of medical consultation.

American College of Chest Physicians. Kesten Hiperzecrecion, Rebuck AS. Official Statement of the European Respiratory Society.

Prueba broncodilatadora | Trisán Alonso | Revista de asma

A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type.

Tashkin D, Kesten S.

Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.